sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

South And Central America Gastrointestinal Drugs Market Scope And Analysis

  • Report Code : TIPRE00016303
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 133
Buy Now

South & Central America Gastrointestinal Drugs Market Scope and Key Players Analysis by 2027

Buy Now

South & Central America Gastrointestinal Drugs Market Report South & Central America Gastrointestinal Drugs Market Size and Share South & Central America Gastrointestinal Drugs Market Scope and Analysis

South & Central America Gastrointestinal Drugs Market Report Scope

Report Attribute Details
Market size in 2019 US$ 4,160.28 Million
Market Size by 2027 US$ 5,632.72 Million
Global CAGR (2020 - 2027) 4.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Drug Class
  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
By Route of Administration
  • Oral
  • Parenteral
By Application
  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Celltrion Healthcare Co Ltd
  • GlaxoSmithKline plc
  • Johnson and Johnson Services Inc
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited
    		•